103 related articles for article (PubMed ID: 29174182)
21. Corrigendum to "Genetic heterogeneity after first-line chemotherapy in high-grade serous ovarian cancer" [Eur J Cancer 53 (2016) 51-64].
Lambrechts S; Smeets D; Moisse M; Braicu EI; Vanderstichele A; Zhao H; Van Nieuwenhuysen E; Berns E; Sehouli J; Zeillinger R; Darb-Esfahani S; Castillo-Tong DC; Lambrechts D; Vergote I
Eur J Cancer; 2016 Jun; 60():226. PubMed ID: 27106403
[No Abstract] [Full Text] [Related]
22. Corrigendum to "Evaluation of breast cancer malignancy, prognostic factors and molecular subtypes using a continuous-time random-walk MR diffusion model" [Eur. J. Radiol. 166 (2023) 111003].
Chang H; Wang D; Li Y; Xiang S; Yang YX; Kong P; Fang C; Ming L; Wang X; Zhang C; Jia W; Yan Q; Liu X; Zeng Q
Eur J Radiol; 2023 Dec; 169():111158. PubMed ID: 37897958
[No Abstract] [Full Text] [Related]
23. Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer.
Lanigan F; McKiernan E; Brennan DJ; Hegarty S; Millikan RC; McBryan J; Jirstrom K; Landberg G; Martin F; Duffy MJ; Gallagher WM
Int J Cancer; 2009 May; 124(9):2088-97. PubMed ID: 19142967
[TBL] [Abstract][Full Text] [Related]
24. Corrigendum to "Predicting and preventing thromboembolic events in patients receiving cisplatin-based chemotherapy for germ cell tumours" [Eur J Cancer 69 (2016) 151-157].
Gizzi M; Oberic L; Massard C; Poterie A; Le Teuff G; Loriot Y; Albiges L; Baciarello G; Michels J; Bossi A; Blanchard P; Escudier B; Fizazi K
Eur J Cancer; 2017 Apr; 75():333. PubMed ID: 28283351
[No Abstract] [Full Text] [Related]
25. Prognostic significance of Claudin 12 in estrogen receptor-negative breast cancer.
Iravani O; Yip GW; Thike AA; Chua PJ; Jane Scully O; Tan PH; Bay BH
J Clin Pathol; 2016 Oct; 69(10):878-83. PubMed ID: 26926102
[TBL] [Abstract][Full Text] [Related]
26. Corrigendum to "Cost-effectiveness analysis in melanoma detection: A transition model applied to dermoscopy" [Eur J Cancer 67 (2016) 38-45].
Tromme I; Legrand C; Devleesschauwer B; Leiter U; Suciu S; Eggermont A; Sacré L; Baurain JF; Thomas L; Beutels P; Speybroeck N
Eur J Cancer; 2017 Sep; 82():247. PubMed ID: 28662904
[No Abstract] [Full Text] [Related]
27. Corrigendum to 'Targeting FGFR2 with alofanib (RPT835) shows potent activity in tumour models' [Eur J Cancer 61 (2016) 20-28].
Tsimafeyeu I; Ludes-Meyers J; Stepanova E; Daeyaert F; Khochenkov D; Joose JB; Solomko E; Van Akene K; Peretolchina N; Yin W; Ryabaya O; Byakhov M; Tjulandin S
Eur J Cancer; 2017 Jan; 70():156. PubMed ID: 27919550
[No Abstract] [Full Text] [Related]
28. EFA6B antagonizes breast cancer.
Zangari J; Partisani M; Bertucci F; Milanini J; Bidaut G; Berruyer-Pouyet C; Finetti P; Long E; Brau F; Cabaud O; Chetaille B; Birnbaum D; Lopez M; Hofman P; Franco M; Luton F
Cancer Res; 2014 Oct; 74(19):5493-506. PubMed ID: 25115298
[TBL] [Abstract][Full Text] [Related]
29. Corrigendum to "Borderline tumours of the ovary: A cohort study of the Arbeitsgemeinschaft Gynäkologische Onkologie AGO Study Group" [Eur J Cancer 49 (2013) 1905-1914].
du Bois A; Ewald-Riegler N; de Gregorio N; Reuss A; Mahner S; Fotopoulou C; Kommoss F; Schmalfeldt B; Hilpert F; Fehm T; Burges A; Meier W; Hillemanns P; Hanker L; Hasenburg A; Strauss HG; Hellriegel M; Wimberger P; Keyver-Paik MD; Baumann K; Canzler U; Wollschlaeger K; Forner D; Pfisterer J; Schröder W; Münstedt K; Richter B; Kommoss S; Hauptmann S
Eur J Cancer; 2016 Sep; 65():192-193. PubMed ID: 27468640
[No Abstract] [Full Text] [Related]
30. Corrigendum on: Andersson JK, Strömberg J, Karlsson J and Fridén J. Patients with triangular fibrocartilage complex injuries and distal radioulnar joint instability have reduced rotational torque in the forearm. J Hand Surg Eur. 2016, 41: 732-738.
J Hand Surg Eur Vol; 2016 Sep; 41(7):NP2. PubMed ID: 27106034
[No Abstract] [Full Text] [Related]
31. Corrigendum to "Nuclear transportation of exogenous epidermal growth factor receptor and androgen receptor via extracellular vesicles" [Eur J Cancer 70 (2017) 62-74].
Read J; Ingram A; Al Saleh HA; Platko K; Gabriel K; Kapoor A; Pinthus J; Majeed F; Qureshi T; Al-Nedawi K
Eur J Cancer; 2017 Sep; 83():335. PubMed ID: 28764945
[No Abstract] [Full Text] [Related]
32. Proteomic and bioinformatic analysis of epithelial tight junction reveals an unexpected cluster of synaptic molecules.
Tang VW
Biol Direct; 2006 Dec; 1():37. PubMed ID: 17156438
[TBL] [Abstract][Full Text] [Related]
33. 'Corrigendum to "Severe hepatitis under combined immunotherapy: Resolution under corticosteroids plus anti-thymocyte immunoglobulins" [Eur J Cancer 81 (August 2017) 203-205]'.
Spänkuch I; Gassenmaier M; Tampouri I; Noor S; Forschner A; Garbe C; Amaral T
Eur J Cancer; 2017 Dec; 87():221. PubMed ID: 28986136
[No Abstract] [Full Text] [Related]
34. Corrigendum to: Recent advances in the discovery of heparanase inhibitors as anti-cancer agents [Eur. J. Mech. 121 (2016) 209-220].
Jia L; Ma S
Eur J Med Chem; 2017 Jan; 125():793-794. PubMed ID: 27741490
[No Abstract] [Full Text] [Related]
35. Tight junction disruption: Helicobacter pylori and dysregulation of the gastric mucosal barrier.
Caron TJ; Scott KE; Fox JG; Hagen SJ
World J Gastroenterol; 2015 Oct; 21(40):11411-27. PubMed ID: 26523106
[TBL] [Abstract][Full Text] [Related]
36. Re: Sakorafas GH, Geraghty J, Pavlakis G. The clinical significance of axillary lymph node micrometastases in breast cancer. Eur J Surg Oncol 2004;30(8):807-16.
Meijnen P; Rutgers EJ
Eur J Surg Oncol; 2005 Oct; 31(8):927. PubMed ID: 15951151
[No Abstract] [Full Text] [Related]
37. Corrigendum to "Understanding organellar protein folding capacities and assessing their pharmacological modulation by small molecules" [Eur. J. Cell Biol. 97 (2018) 114-125].
Sharma R; Pramanik MMD; Chandramouli B; Rastogi N; Kumar N
Eur J Cell Biol; 2020 Apr; 99(2-3):151074. PubMed ID: 32223913
[No Abstract] [Full Text] [Related]
38. Corrigendum to "Aiming for a holistic integrated service for men diagnosed with prostate cancer - Definitions of standards and skill sets for nurses and allied healthcare professionals" [Eur. J. Oncol. Nurs. 29 (2017) 31-38].
Lamb AD; Thompson S; Kinsella N; Gerbitz I; Chapman E; Putt L; Bennett S; Thankappannair V; Geoghegan L; Wright N; Stirton-Croft A; Nixon P; Styling A; Whitney D; Hodgson L; Punt L; Longmore J; Carter M; Petch B; Rimmer Y; Russell S; Hughes-Davies L; Mazhar D; Shah NC; Gnanapragasam VJ; Doble A; Bratt O; Kastner C
Eur J Oncol Nurs; 2017 Oct; 30():59. PubMed ID: 29031314
[No Abstract] [Full Text] [Related]
39. JAM-A expression positively correlates with poor prognosis in breast cancer patients.
McSherry EA; McGee SF; Jirstrom K; Doyle EM; Brennan DJ; Landberg G; Dervan PA; Hopkins AM; Gallagher WM
Int J Cancer; 2009 Sep; 125(6):1343-51. PubMed ID: 19533747
[TBL] [Abstract][Full Text] [Related]
40. Dietary riboflavin deficiency decreases immunity and antioxidant capacity, and changes tight junction proteins and related signaling molecules mRNA expression in the gills of young grass carp (Ctenopharyngodon idella).
Chen L; Feng L; Jiang WD; Jiang J; Wu P; Zhao J; Kuang SY; Tang L; Tang WN; Zhang YA; Zhou XQ; Liu Y
Fish Shellfish Immunol; 2015 Aug; 45(2):307-20. PubMed ID: 25882633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
